Advertisement
New Zealand markets closed

  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     

  • NZD/USD

    0.5952
    +0.0003 (+0.05%)
     

  • NZD/EUR

    0.5561
    +0.0021 (+0.38%)
     

  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     

  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     

  • OIL

    83.72
    +0.15 (+0.18%)
     

  • GOLD

    2,351.20
    +8.70 (+0.37%)
     

  • NASDAQ

    17,688.22
    +257.72 (+1.48%)
     

  • FTSE

    8,139.78
    +60.92 (+0.75%)
     

  • Dow Jones

    38,262.44
    +176.64 (+0.46%)
     

  • DAX

    18,184.28
    +267.00 (+1.49%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • NZD/JPY

    93.4520
    +0.9560 (+1.03%)
     

Prince Charles opens new AstraZeneca research center

Reuters Videos
Updated

AstraZeneca has supplied two billion doses of its COVID-19 vaccine, developed at Oxford University, and is also looking to bring a preventative antibody cocktail against COVID-19 to market.

Prince Charles, son of Queen Elizabeth and heir to the throne, saw an exhibit on the pandemic and a demonstration of how augmented reality headsets can help with lab work, before hearing about the company's net-zero targets.

Chief Executive Pascal Soriot, who accompanied Charles on a tour through the facility, said the centre would "power the next stage of our company's growth."

AstraZeneca, which has a large portfolio of treatments for diseases such as cancer, heart disease and diabetes, said the centre would support research into specialized medicines and next-generation therapeutics, including gene-editing and cell therapies.